Results for Neurodegeneration

Publications & Outputs

1. Size-resolved, quantitative evaluation of the magnetic mineralogy of airborne brake-wear particulate emissions

   Gonet, T., Maher, B. A., Nyirő-Kósa, I., Pósfai, M., Vaculík, M. & Kukutschová, J., 1/11/2021, In: Environmental Pollution. 288, 12 p., 117808.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

2. Prolific shedding of magnetite nanoparticles from banknote surfaces

   Maher, B. A. & Gonet, T., 10/05/2021, In: Science of the Total Environment. 768, 9 p., 144490.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

3. Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models

   Hölscher, C., 1/07/2018, In: Neuropharmacology. 136, Part B, p. 251-259 9 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

4. GLP-1 receptor agonists show neuroprotective effects in animal models of diabetes

   Gault, V. A. & Hölscher, C., 02/2018, In: Peptides. 100, p. 101-107 7 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

5. Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease

   Tai, J., Liu, W., Li, Y., Li, L. & Hölscher, C., 1/01/2018, In: Brain Research. 1678, p. 64-74 11 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

6. A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease

   Jalewa, J., Sharma, M. K., Gengler, S. & Hölscher, C., 1/05/2017, In: Neuropharmacology. 117, p. 238-248 11 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

7. Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson's disease

   Chen, Y., Zhang, Y., Li, L. & Holscher, C., 5/12/2015, In: European Journal of Pharmacology. 768, p. 21-27 7 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

8. Neuroprotective effects of an oxyntomodulin analogue in the MPTP mouse model of Parkinson's disease

   Liu, W., Li, Y., Jalewa, J., Saunders-Wood, T., Li, L. & Hölscher, C., 2015, In: European Journal of Pharmacology. 765, p. 284-290 7 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

9. First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease

   Hölscher, C., 02/2014, In: Alzheimer's and Dementia. 10, 1 Supplement, p. S33-37 5 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

10. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer ‘s disease

    McClean, P. L. & Holscher, C., 2013, In: Neuropharmacology. 76, Part A, p. 57-67 11 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

11. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology

    Kar, S., Poirier, J., Guevara, J., Dea, D., Hawkes, C., Robitaille, Y. & Quirion, R., 1/02/2006, In: Neurobiology of Aging. 27, 2, p. 199-210 12 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

More results »